Home » IFPMA Strengthens Ethics Code, Calls for Balanced Drug Ads
IFPMA Strengthens Ethics Code, Calls for Balanced Drug Ads
March 8, 2012
A new code of ethical business practice adopted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) calls for strict adherence to global regulatory standards, balanced and accurate drug promotions and greater transparency in industry-sponsored clinical trials.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor